Skip to main content
Clinical Trials/NCT04931511
NCT04931511
Terminated
Phase 4

Comparison Between Subacromial Ultrasound Guided and Systemic Steroid Injection for Frozen Shoulder: a Randomized Double Blind Study

Second Affiliated Hospital, School of Medicine, Zhejiang University1 site in 1 country20 target enrollmentJune 1, 2021

Overview

Phase
Phase 4
Intervention
Compound betamethasone Injection(Gluteal muscle injection)
Conditions
Frozen Shoulder
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment
20
Locations
1
Primary Endpoint
The Change of Shoulder Pain and Disability Index (SPADI)
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

This study aim to compare the efficacy of guteal muscle injection and subacromial ultrasound guided injection to treat frozen shoulder. Firstly, in order to calculate the sample size correctly, we start the preliminary study. Besides, in order to propose clinical new technology which combines the advantages of the two therapies, improve the efficacy ratio of frozen shoulder therapy, and provide a frozen shoulder treatment plan according to health economics.

Detailed Description

In recent years, there have been studies suggesting that small doses of corticosteroid systemic medication and joint local injection to treat shoulder sleeve disease is equivalent, frozen shoulder is clinically in addition to shoulder sleeve disease another common cause of shoulder pain disease, local injection of small dose of corticosteroid is a clinically commonly used treatment of frozen shoulder mature therapy, however, because of the risk of joint infection and other serious complications, and it's personnel experience depended and high qualification requirements, resulting in higher treatment costs. However, it has not been widely used in clinical applications and is generally used as a second-line therapy for the treatment of frozen shoulders. There are studies suggesting that joint cavity hormone injection may be mainly effective through its systemic effect, however, there is currently no random blind control study comparing small doses of hormone systemic injection with local injection of shoulder joints to freeze shoulder, if the equivalence of the two can be confirmed through such studies will greatly change the clinical treatment of frozen shoulders, with hip injection and other systemic medication will provide great health economic advantages, and can avoid the inherent risk of joint cavity injection, reduce the social cost of frozen shoulder treatment.

Registry
clinicaltrials.gov
Start Date
June 1, 2021
End Date
September 1, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible Party
Principal Investigator
Principal Investigator

huang pintong

Director of the department of ultrasound

Second Affiliated Hospital, School of Medicine, Zhejiang University

Eligibility Criteria

Inclusion Criteria

  • Primary frozen shoulder
  • Older than 18 years of age and less than 75 years of age
  • The SHOULDER PAIN VAS SCORE IS GREATER THAN 3 POINTS AND LASTS AT LEAST 1 MONTH AND LESS THAN 9 MONTHS
  • The passive activity of the side shoulder joint in at least 2 directions in the three directions of front, internal and outer rotation decreased by more than 30 degrees compared to the side shoulder joint or the normal reference value
  • corticosteroid injections were not given within 3 months of visit

Exclusion Criteria

  • A history of trauma, osteoarthritis, tumors, etc.
  • Combined shoulder sleeve injury with magnetic resonance or B-mode ultrasound confirmed
  • There is a history of corticosteroid injections within 3 months of visit
  • Suffer from a partial infection of the side shoulder or other cases where there is a contraindication of shoulder injection
  • Both side shoulder joints become ill at the same time
  • The patient has not signed an informed consent form

Arms & Interventions

Gluteal muscle injection plus physical therapy group

Gluteal muscle injection (corticosteroid 1ml+normal saline 4ml) + Subacromial Ultrasound Guided injection (sodium chloride 5ml) + Physical therapy

Intervention: Compound betamethasone Injection(Gluteal muscle injection)

Gluteal muscle injection plus physical therapy group

Gluteal muscle injection (corticosteroid 1ml+normal saline 4ml) + Subacromial Ultrasound Guided injection (sodium chloride 5ml) + Physical therapy

Intervention: Physical therapy

Subacromial Ultrasound Guided injection plus physical therapy group

Gluteal muscle injection(sodium chloride 5ml)) + Subacromial Ultrasound Guided injection(corticosteroid 1ml+normal saline 4ml) + Physical therapy

Intervention: Compound betamethasone Injection(Subacromial Ultrasound Guided injection)

Subacromial Ultrasound Guided injection plus physical therapy group

Gluteal muscle injection(sodium chloride 5ml)) + Subacromial Ultrasound Guided injection(corticosteroid 1ml+normal saline 4ml) + Physical therapy

Intervention: Physical therapy

Outcomes

Primary Outcomes

The Change of Shoulder Pain and Disability Index (SPADI)

Time Frame: 0,1,2,4,8,12 weeks

The SPADI contains 13 items that assess two domains; a 5-item subscale that measures pain and an 8-item subscale that measures disability.

Secondary Outcomes

  • Anterior flexion of shoulder joint (0-180°)(0,1,2,4,8,12 weeks)
  • shoulder external rotator (0-180°)(0,1,2,4,8,12 weeks)
  • The Change of Numeric Rating Scale for Pain (NRS) (Score: 0-10)(0,1,2,4,8,12 weeks)
  • shoulder joint abduction (0-180°)(0,1,2,4,8,12 weeks)
  • shoulder internal rotator (1-18 score)(0,1,2,4,8,12 weeks)

Study Sites (1)

Loading locations...

Similar Trials